Celebrex May Reduce Skin Cancer

A twice-daily dose of  Celebrex over a period of nine months reduced the incidence of nonmelanoma skin cancer by almost 60 percent, according a new study. Read on..SID: COX-2 Inhibitors May Cut Skin Cancer Rate


Other articles you may be interested in...